This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
660 W Germantown Pike Ste 100
Plymouth Meeting, Pennsylvania 19462
Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that has reported generating T cells in vivo in high quantity that are fully functional and whose killing capacity ... more
Senior Vice President and Chief Medical Officer
Vice President, Global Medical Affairs, Oncology
Vice President, Global Head Medical Affairs and PV, Medical Diagnostics and NPD
Global Therapeutic Area Director of Oncology
University of Virginia's School of Medicine
Mark Stephen Gelder
, M.D., an experienced gynecologic oncologist, was appointed Vice President, Clinical Development to lead Inovio's clinical development of its immunotherapies against HPV-caused cervical cancer and dysplasia, including our planned phase III study for VGX-3100.
Clinical Research News and Views on the Global Clinical Trials Industry | CenterWatch News Online
Heron Therapeutics â€¢ A Biotechnology Company
Linda Van Gelder
The World Bank
Michael Van Gelder
Vorwerk International Strecker & Co.
Dairy Australia Limited
Susan Van Gelder
Kutak Rock LLP